Form 8-K · Current Report · Filed 2026-05-20

Gilead Sciences Announces Issuance of Senior Notes

On May 20, 2026, Gilead Sciences, Inc. announced the issuance of $500,000,000 aggregate principal amount of 4.250% Senior Notes due 2028, $1,000,000,000 aggregate principal amount of 4.400% Senior Notes due 2029, $1,000,000,000 aggregate principal amount of 4.600% Senior Notes due 2031, and $500,000,000 aggregate principal amount of 4.900% Senior Notes due 2034. The net proceeds from the sale of the Notes will be used for general corporate purposes, including funding for acquisitions, investments, strategic transactions, or other business opportunities. The issuance is subject to certain restrictions, including limitations on creating or incurring secured indebtedness and entering into sale and leaseback transactions. The company may redeem some or all of the Notes at any time and from time to time at the applicable redemption prices.